MDA (Medical Devices Agency) issues decontamination warning:
This article was originally published in Clinica
The UK Medical Devices Agency continues to receive reports about damage to medical devices and reprocessing equipment due to the use of incompatible decontamination agents or processes. It is calling on the relevant healthcare departments to heed manufacturers' instructions regarding deontamination. This information should include the type of agent that may be used and warnings on agents and processes known to be detrimental to the device, says the agency. It adds that new devices should only be purchased after ensuring that appropriate facilities and compatible agents are available. The MDA has also renewed its warning to "never reuse devices designated for single use".
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.